{"date":"2026-11-18","count":15,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7827-2026-11-18-1938-1m1ufkq","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-11-18","time":"19:38:04","subject":"代子公司FBD Biologics Limited公告，美國 FDA 通知 HCB301 新藥臨床試驗申請（IND 170769）實施臨床暫停","clause":"第10款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-11-18 19:38，「代子公司FBD Biologics Limited公告，美國 FDA 通知 HCB301 新藥臨床試驗申請（IND 17」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-11-18-1849-x9frv2","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-11-18","time":"18:49:11","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告2026年第一次股東臨時會決議事項","clause":"第18款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-11-18 18:49，「代重要子公司合富（中國）醫療科技股份有限公司公告2026年第一次股東臨時會決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-11-18-1817-1vzefk3","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-11-18","time":"18:17:47","subject":"公告本公司受邀參加宏遠證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-11-19","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-11-18 18:17，「公告本公司受邀參加宏遠證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-11-18-1737-1jnekfl","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-11-18","time":"17:37:27","subject":"公告本公司115年現金增資委託代收價款及存儲專戶機構","clause":"第44款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-11-18 17:37，「公告本公司115年現金增資委託代收價款及存儲專戶機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-11-18-1733-5xp9q1","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-11-18","time":"17:33:04","subject":"公告本公司配合會計師事務所內部調整更換簽證會計師","clause":"第7款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-11-18 17:33，「公告本公司配合會計師事務所內部調整更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-11-18-1704-142ih3h","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-11-18","time":"17:04:08","subject":"公告本公司證券簡稱由「沛爾生醫*-創」變更為「沛爾*-創」","clause":"第51款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-11-18 17:04，「公告本公司證券簡稱由「沛爾生醫*-創」變更為「沛爾*-創」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-11-18-1600-1aq7iqo","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-11-18","time":"16:00:09","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-11-19","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-11-18 16:00，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2026-11-18-1545-16sohr8","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2026-11-18","time":"15:45:12","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-11-25","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2026-11-18 15:45，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-11-18-1532-qwd6um","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-11-18","time":"15:32:16","subject":"公告本公司115年現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-11-18 15:32，「公告本公司115年現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-11-18-1513-1oxqq17","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-11-18","time":"15:13:57","subject":"公告本公司授權山東新時代藥業有限公司之鹽酸沙丙蝶呤片(Sapropterin Dihydrochloride)獲中國國家醫療保障局核准納入國家醫保藥品目錄","clause":"第44款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-11-18 15:13，「公告本公司授權山東新時代藥業有限公司之鹽酸沙丙蝶呤片(Sapropterin Dihydrochloride)獲中國國家」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-11-18-1509-i34k4g","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-11-18","time":"15:09:50","subject":"公告本公司董事會決議115年度現金增資發行價格區間調整案","clause":"第9款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-11-18 15:09，「公告本公司董事會決議115年度現金增資發行價格區間調整案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4109-2026-11-18-1502-1cp75gv","company_id":"4109","company":"加捷生醫","market":"上櫃","industry":"生技醫療","date":"2026-11-18","time":"15:02:51","subject":"本公司受邀參加群益金鼎證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-11-19","cite_as":"公開資訊觀測站重大訊息：加捷生醫（4109），2026-11-18 15:02，「本公司受邀參加群益金鼎證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-11-18-1418-16sohr8","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-11-18","time":"14:18:48","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-11-25","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-11-18 14:18，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-11-18-1333-1ghvevw","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-11-18","time":"13:33:34","subject":"本公司受邀參加財團法人中華民國證券櫃檯買賣中心舉辦之業績發表會","clause":"第12款","fact_date":"2026-11-24","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-11-18 13:33，「本公司受邀參加財團法人中華民國證券櫃檯買賣中心舉辦之業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-11-18-0954-1ov9ga2","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-11-18","time":"09:54:22","subject":"公告本公司私募普通股收足股款暨增資基準日","clause":"第53款","fact_date":"2026-11-18","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-11-18 09:54，「公告本公司私募普通股收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}